CAV VACCINE

国: オーストラリア

言語: 英語

ソース: APVMA (Australian Pesticides and Veterinary Medicines Authority)

有効成分:

CHICKEN ANAEMIA VIRUS (LIVE) STRAIN 3711

から入手可能:

INTERVET AUSTRALIA PTY LIMITED

INN（国際名）:

CAV (live) - 3711

医薬品形態:

MISC. VACCINES OR ANTI SERA

構図:

CHICKEN ANAEMIA VIRUS (LIVE) STRAIN 3711 VACCINE-VIRAL Active 0.0 P

パッケージ内のユニット:

500 Doses; per vial

クラス:

VM - Veterinary Medicine

製:

INTERVET AUSTRALIA

治療群:

POULTRY CHICKS | CHICKENS | DAY OLD CHICKS | HATCHLINGS

治療領域:

IMMUNOTHERAPY

適応症:

CAV DISEASE

製品概要:

Poison schedule: 0; Withholding period: WHP: Do not use in laying birds where eggs or egg products are to be used for human consumption or processing.; Host/pest details: POULTRY CHICKS: [CAV DISEASE]; Poison schedule: 0; Withholding period: ; Host/pest details: POULTRY CHICKS: [CAV DISEASE]; For the prevention of CAV disease in progeny of broiler breeders.

認証ステータス:

Registered

承認日:

2023-07-01

情報リーフレット

Bartter Enterprises CAV Vaccine Vial Label - Version 4
A.C.N. 000 451 374
Page 1 of 1 12/9/2000
VIAL –
LABEL APPROVED BY NRA. REFERENCE NUMBER: NRA - 48988/ 1099
All letters are to be at least 6 point (Upper case 1.5mm , Lower case
1mm).
Final label size: 70 x 25 mm
FOR ANIMAL TREATMENT ONLY
_ _
_CAV VACCINE_
CHICKEN ANAEMIA VIRUS (LIVE), STRAIN 3711
For the prevention of CAV disease in progeny of broiler breeders.
500 DOSES,
WHP
: Do not use in layers.
READ ENCLOSED LEAFLET
Store below –18
0
C (deep freeze).
Bartter Enterprises A.C.N. 000 451 374
NRA
: 4
8988/1099
[B]
.
Exp.
Info
PEST
✔
Verified
Bartter Enterprises
CAV VACCINE LEAFLET – VERSION 3
ACN 000 451 374
Page 1 of 1
FOR ANIMAL TREATMENT ONLY
_CAV VACCINE_
CONTAINS
≥
≥≥
≥ 1.575
CID
50 /DOSE CHICKEN ANAEMIA VIRUS (LIVE), STRAIN 3711
FOR THE PREVENTION OF CAV DISEASE IN PROGENY OF BROILER BREEDERS.
500 DOSES PER VIAL
DIRECTIONS FOR USE
RESTRAINT: Do not use in laying birds where eggs or egg products are
to be used for human consumption or processing.
PRECAUTIONS:
CAV vaccine should be administered to replacement breeder stock from
10-16 weeks of age and before they come into contact
with flocks-in-lay for which the CAV antibody status is unknown or
negative. If the vaccine were to spread from the flock
undergoing vaccination to flocks in lay that are not already
antibody-positive to CAV, a wave of disease associated with CAV
could occur in the progeny of antibody-negative layers as they become
infected and before they develop immunity to CAV.
DOSAGE AND ADMINISTRATION
_Oral vaccination:_
_ _
Calculate the amount of vaccine needed to vaccinate a minimum of 20%
of the flock. Two vials of CAV
vaccine are added to each bottle of diluent (50 mL) for each 1,000
birds. Transfer reconstituted vaccine to dropper bottles
supplied. A minimum of 20% of the flock is to be vaccinated and must
include birds in every pen or cage. Hold each bird to be
vaccinated firmly. Use your fingers to gently open the bird's mouth
and put one drop of vaccine into the mou

製品の特徴

PRODUCT NAME: CAV VACCINE
MATERIAL SAFETY DATA SHEET
THIS REVISION ISSUED: JULY, 2009
PAGE: 1 OF 5
MATERIAL SAFETY DATA SHEET
Issued by: Intervet Australia Pty Limited Phone: [phone]
(Business Hours)
Poisons Information Centre: 13 11 26 from anywhere in Australia, (0800
764 766 in New Zealand)
SUBSTANCE:
Preparation of freeze-dried, live virus and other ingredients.
TRADE NAME:
CAV VACCINE
PRODUCT CODE:
3949
RECOMMENDED USE:
For protection of chicken progeny against Chicken Anaemia Virus (CAV)
by immunisation
of breeders.
APVMA NO:
48988
CREATION DATE:
November, 2006
THIS VERSION ISSUED:
July, 2009
and is valid for 5 years from this date.
STATEMENT OF HAZARDOUS NATURE:
THIS PRODUCT IS CLASSIFIED AS:
Not classified as hazardous according to the criteria of SWA.
Not a Dangerous Good according to the Australian Dangerous Goods (ADG)
Code.
RISK PHRASES:
Not Hazardous - No criteria found.
SAFETY PHRASES:
S45. In case of accident or if you feel unwell, contact a doctor or
Poisons Information Centre
immediately (show the label where possible).
SUSDP CLASSIFICATION:
None allocated.
ADG CLASSIFICATION:
None allocated. Not a Dangerous Good under the ADG Code.
UN NUMBER:
None allocated
PHYSICAL DESCRIPTION & COLOUR:
The vaccine is a freeze-dried, live virus vaccine, presented in 9mL
glass vials
that have been sealed under vacuum and in which there is a 1.0mL plug
of dried vaccine.
ODOUR:
No odour.
MAJOR HEALTH HAZARDS:
no significant risk factors have been found for this product.
INHALATION:
SHORT TERM EXPOSURE:
Available data indicates that this product is not harmful. In addition
product is unlikely to
cause any discomfort or irritation.
LONG TERM EXPOSURE:
No data for health effects associated with long term inhalation.
SKIN CONTACT:
SHORT TERM EXPOSURE:
Available data indicates that this product is not harmful. It should
present no hazards in
normal use. In addition product is unlikely to cause any discomfort in
normal use.
LONG TERM EXPOSURE:
No data for health effects associated with long term skin exposure.
EYE